Latest goodwill for 0RKL.L: $650M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), 0RKL.L shows a goodwill of $650M. That compares with $620M in the prior-year period — up 3.9% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 0RKL.L's goodwill is now $650M (was $620M) — a 3.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Xvivo Perfusion AB (publ) is outperforming or lagging.
Tracking 0RKL.L's goodwill over time shows whether Xvivo Perfusion AB (publ) is scaling, shrinking, or reshaping that part of the business. The current reading is $650M That compares with $620M in the prior-year period — up 3.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this goodwill page, Stockcircle has Xvivo Perfusion AB (publ)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $650M) with ownership activity and broader fundamentals.